TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against MoonLake Immunotherapeutics alleging securities fraud related to misrepresentations about their drug candidate sonelokimab, which led to significant stock value loss.

Insights
CSCO   neutral

Mentioned as a top holding in the Schwab U.S. Dividend Equity ETF without specific individual analysis


MLTX   negative

Stock lost nearly 90% of its value after Phase 3 trial results revealed alleged misrepresentations about drug efficacy, with lawsuit claiming false statements about drug candidate sonelokimab's performance